Brief: Orchestra Biomed Secures Over $111 Million In Proceeds And Committed Capital Following Completion Of Strategic Transactions And Concurrent Public And Private Equity Offerings
Orchestra Biomed Holdings Inc OBIO.O: ORCHESTRA BIOMED SECURES OVER $111 MILLION IN PROCEEDS AND COMMITTED CAPITAL FOLLOWING COMPLETION OF STRATEGIC TRANSACTIONS AND CONCURRENT PUBLIC AND PRIVATE EQUITY OFFERINGS ORCHESTRA BIOMED HOLDINGS INC - PROCEEDS EXTEND CASH RUNWAY INTO 2027 FOR TRIALS Source text: ID:nGNX7gnMD2 Further company coverage: OBIO.O
Recent news on Orchestra Biomed Holdings
See all newsBrief: Orchestra Biomed Announces Pricing Of Public Offering
Orchestra BioMed slides after starting equity offering
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens